Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Erianin may effectively treat alopecia areata by targeting the immune system.

Vaccination is the most effective way to reduce COVID-19 transmission.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Effective delivery systems are crucial for siRNA hair loss treatments to work better.

Gut bacteria differences could help diagnose and treat alopecia areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

The link between anabolic agents and colorectal cancer risk is unclear.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Dupilumab users have a higher risk of developing alopecia areata.

Aging and chronic diseases impair muscle repair, but integrated therapies like exercise and gene editing may help.

Belatacept may be a promising treatment for alopecia areata.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

New drug delivery systems show promise in effectively treating pathological scars.

Understanding hair growth pathways can lead to better hair loss treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

New treatments like nanotechnology show promise in improving skin cancer therapy.